RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CStone Pharmaceuticals Stock

CStone Pharmaceuticals EBIT 2024

CStone Pharmaceuticals EBIT

-43.18 M CNY

Ticker

2616.HK

ISIN

KYG2588M1006

WKN

A2PEFW

In 2024, CStone Pharmaceuticals's EBIT was -43.18 M CNY, a -92.2% increase from the -553.45 M CNY EBIT recorded in the previous year.

The CStone Pharmaceuticals EBIT history

YEAREBIT (undefined CNY)
2026e107.21
2025e-93.47
2024e-43.18
2023-553.45
2022-880.02
2021-1,793.43
2020-1,062.43
2019-1,713.16
2018-1,017.03
2017-242.33
2016-262.08

CStone Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CStone Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CStone Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CStone Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CStone Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CStone Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CStone Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CStone Pharmaceuticals’s growth potential.

CStone Pharmaceuticals Revenue, EBIT and net profit per share

DateCStone Pharmaceuticals RevenueCStone Pharmaceuticals EBITCStone Pharmaceuticals Net Income
2026e931.67 M undefined107.21 M undefined-182.29 M undefined
2025e683.03 M undefined-93.47 M undefined-253.9 M undefined
2024e535.17 M undefined-43.18 M undefined-247.39 M undefined
2023463.84 M undefined-553.45 M undefined-367.23 M undefined
2022481.36 M undefined-880.02 M undefined-902.68 M undefined
2021243.72 M undefined-1.79 B undefined-1.92 B undefined
20201.04 B undefined-1.06 B undefined-1.22 B undefined
20190 undefined-1.71 B undefined-2.07 B undefined
20180 undefined-1.02 B undefined-469.83 M undefined
20170 undefined-242.33 M undefined-107.45 M undefined
20160 undefined-262.08 M undefined-117.11 M undefined

CStone Pharmaceuticals stock margins

The CStone Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CStone Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CStone Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CStone Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the CStone Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CStone Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CStone Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CStone Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CStone Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CStone Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CStone Pharmaceuticals Margin History

CStone Pharmaceuticals Gross marginCStone Pharmaceuticals Profit marginCStone Pharmaceuticals EBIT marginCStone Pharmaceuticals Profit margin
2026e65.6 %11.51 %-19.57 %
2025e65.6 %-13.68 %-37.17 %
2024e65.6 %-8.07 %-46.23 %
202365.6 %-119.32 %-79.17 %
202257.83 %-182.82 %-187.53 %
202156.17 %-735.86 %-787.84 %
202076.76 %-102.27 %-117.54 %
201965.6 %0 %0 %
201865.6 %0 %0 %
201765.6 %0 %0 %
201665.6 %0 %0 %

CStone Pharmaceuticals Aktienanalyse

What does CStone Pharmaceuticals do?

CStone Pharmaceuticals is a biopharmaceutical company founded in January 2016 by a team of experienced industry leaders. The company is headquartered in Suzhou, China, and focuses on the discovery, development, and commercialization of innovative therapeutics in the fields of oncology, immunology, and metabolic disorders. CStone aims to improve healthcare worldwide and extend and enhance the lives of patients through the development of cutting-edge medical solutions. CStone Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing CStone Pharmaceuticals's EBIT

CStone Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of CStone Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

CStone Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in CStone Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about CStone Pharmaceuticals stock

How much did CStone Pharmaceuticals achieve in EBIT for the current year?

In the current year, CStone Pharmaceuticals has achieved an EBIT of -43.18 M CNY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company CStone Pharmaceuticals.

How has the EBIT of CStone Pharmaceuticals developed in recent years?

The EBIT of CStone Pharmaceuticals has increased by -92.197% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company CStone Pharmaceuticals?

The EBIT of CStone Pharmaceuticals is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does CStone Pharmaceuticals pay?

Over the past 12 months, CStone Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CStone Pharmaceuticals is expected to pay a dividend of 0 CNY.

What is the dividend yield of CStone Pharmaceuticals?

The current dividend yield of CStone Pharmaceuticals is .

When does CStone Pharmaceuticals pay dividends?

CStone Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CStone Pharmaceuticals?

CStone Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of CStone Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is CStone Pharmaceuticals located?

CStone Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von CStone Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CStone Pharmaceuticals from 10/21/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did CStone Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of CStone Pharmaceuticals in the year 2023?

In the year 2023, CStone Pharmaceuticals distributed 0 CNY as dividends.

In which currency does CStone Pharmaceuticals pay out the dividend?

The dividends of CStone Pharmaceuticals are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CStone Pharmaceuticals

Our stock analysis for CStone Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CStone Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.